Tag archive

EBAY

IMS Health – Think Longer-term

in Stock Analysis

IMS Health (RX) did not have a spectacular quarter to put it mildly. Revenue decline (on constant currency basis) accelerated to 4% from a 2% decline last quarter. Pharmaceutical companies are becoming more stingy and thus RX’s business got pinched. However, most of the revenue damage is taking place on the consulting side of the…

Keep Reading

Go to Top

JOIN OUR NEWSLETTER

Tired of generic investment advice?